Armstrong Henry H Associates Inc Abb Vie Inc. Transaction History

Armstrong Henry H Associates Inc

$1.04 Billion
Q3 2024

A detailed history of Armstrong Henry H Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 17,903 shares of ABBV stock, worth $3.28 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

17,903

Previous 18,693 4.23%

Holding current value

$3.28 Million

Previous $3.21 Million 10.26%

% of portfolio

0.34%

Previous 0.32%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$163.84 - $199.33 $129,433 - $157,470	-790 Reduced 4.23%	17,903 $3.54 Million
Q2 2024 Jul 02, 2024	BUY	$154.79 - $180.76 $2,786 - $3,253	18 Added 0.1%	18,693 $3.21 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $63,928 - $72,840	-400 Reduced 2.1%	18,675 $3.4 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $550,400 - $619,880	-4,000 Reduced 17.33%	19,075 $2.96 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $146,423 - $182,214	-1,105 Reduced 4.57%	23,075 $3.11 Million
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $120,026 - $138,228	-830 Reduced 3.32%	24,180 $3.85 Million
Q4 2022 Jul 10, 2023	BUY	$138.31 - $165.87 $114,797 - $137,672	830 Added 3.43%	25,010 $4.04 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $5,642 - $7,173	41 Added 0.16%	25,010 $3.83 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $27,847 - $34,551	211 Added 0.85%	24,969 $4.05 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $63,840 - $72,468	600 Added 2.48%	24,758 $2.67 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $5,260 - $5,860	-50 Reduced 0.21%	24,158 $2.72 Million
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $12,199 - $14,317	142 Added 0.59%	24,208 $2.12 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $14,674 - $19,636	-200 Reduced 0.82%	24,066 $2.36 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $11,287 - $17,113	-175 Reduced 0.72%	24,266 $1.85 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $62,279 - $76,808	-800 Reduced 3.17%	24,441 $2.25 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $17,956 - $21,246	-200 Reduced 0.79%	25,241 $2.34 Million
Q4 2017 Jan 23, 2018	BUY	$89.56 - $98.21 $53,736 - $58,925	600 Added 2.42%	25,441 $2.46 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $1.74 Million - $2.22 Million	24,841	24,841 $2.21 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.

Account

Armstrong Henry H Associates Inc Abb Vie Inc. Transaction History